Background The role of mineralocorticoid receptor antagonists (MRAs) in acute myocardial infarction (MI) remains ...
A recent post‑hoc analysis of the COMMANDS trial evaluated the benefits of Luspatercept versus Epoetin alfa (EA) in ESA‑naïve ...
Needham analyst Serge Belanger says Trevi Therapeutics (TRVI)’ Phase 2b CORAL trial evaluating Haduvio for idiopathic pulmonary fibrosis cough underwent a successful sample-size re-estimation analysis ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the CABINET phase 3 pivotal trial evaluating CABOMETYX ® (cabozantinib) versus ...
Objective To undertake a contemporary review of the impact of exercise based cardiac rehabilitation (ExCR) for patients with atrial fibrillation (AF). Data sources CENTRAL, MEDLINE, Embase, PsycINFO, ...
Stockhead on MSN
Biocurious: AI becomes the hidden helping hand in clinical trial design and analysis
Drug developers increasingly are harnessing AI to optimise clinical trial patient selection and to interpret results to ...
Ezetimibe is a drug that selectively inhibits cholesterol absorption and further reduces LDL-C when used in addition to statins. The ENHANCE trial is a randomized study aimed at studying the effect of ...
Patients undergoing cardiac surgery often receive red-cell transfusions, along with the associated risks and costs. Early intraoperative normovolemic hemodilution (i.e., acute normovolemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback